MPG.eBooks - Description: CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas

Read Now

The CADTH Canadian Drug Expert Review Committee (CDEC) recommends that riociguat be listed for the treatment of pulmonary arterial hypertension

Bibliographic Details
Corporate Authors:	CADTH Canadian Drug Expert Committee, Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2015, 2015
Series:	CADTH common drug review
Subjects:	Drug Evaluation Pyrazoles / Therapeutic Use Canada Pyrimidines / Therapeutic Use Hypertension, Pulmonary / Drug Therapy Treatment Outcome
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK538738
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The CADTH Canadian Drug Expert Review Committee (CDEC) recommends that riociguat be listed for the treatment of pulmonary arterial hypertension
Item Description:	"Notice of Final Recommendation - December 17, 2015."
Physical Description:	1 PDF file (6 pages)